Ines Marques-Melo
Coimbra, 3004504, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Emerging Roles of Rivastigmine Derivatives Bearing Antioxidant Motifs as Multi-Target Agents for the Management of Neurodegenerative Diseases.
Journal: International journal of molecular sciences
Published: March 16, 2026
Rivastigmine Templates with Antioxidant Motifs-A Medicinal Chemist's Toolbox Towards New Multipotent AD Drugs.
Journal: Antioxidants (Basel, Switzerland)
Published: May 14, 2025
Bacterial extracellular vesicles at the interface of gut microbiota and immunity.
Journal: Gut microbes
Published: September 28, 2024
Gut-first Parkinson's disease is encoded by gut dysbiome.
Journal: Molecular neurodegeneration
Published: June 13, 2024
Nocardia cyriacigeorgica Elicits Gut Disturbances in a Leaky Gut Model of Colitis, but Not the Harmful Cascade Leading to Gut-First Parkinson's Disease.
Journal: International journal of molecular sciences
Published: January 24, 2024
New Multitarget Rivastigmine-Indole Hybrids as Potential Drug Candidates for Alzheimer's Disease.
Journal: Pharmaceutics
Published: January 15, 2024
Intestinal infection triggers mitochondria-mediated α-synuclein pathology: relevance to Parkinson's disease.
Journal: Cellular and molecular life sciences : CMLS
Published: May 05, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026